Results 1 to 10 of about 13,203 (228)
Comparison between four published definitions of hyposmia in Parkinson's disease [PDF]
Objectives Hyposmia is a common feature of Parkinson's disease (PD), yet there is no standard method to define it. A comparison of four published methods was performed to explore and highlight differences.
Yoav Ben-Shlomo +2 more
exaly +4 more sources
Background Olfaction is a complex process involving different neurological mechanisms with a correlation between the chemical structure and quality of odors regarding pleasantness.
Tamer M. Attia, Ahmad M. Hamdan
doaj +2 more sources
Diagnosis of Anosmia and Hyposmia: A Systematic Review [PDF]
Background Anosmia and hyposmia have many etiologies, including trauma, chronic sinusitis, neoplasms, and respiratory viral infections such as rhinovirus and SARS-CoV-2. We aimed to systematically review the literature on the diagnostic evaluation of anosmia/hyposmia.
Abdul K. Saltagi +7 more
core +5 more sources
Hyposmia: a possible biomarker of Parkinson’s disease [PDF]
Hyposmia, identified as reduced sensitivity to odor, is a common non-motor symptom of Parkinson's disease (PD) that antedates the typical motor symptoms by several years. It occurs in ∼90% of early-stage cases of PD. In addition to the high prevalence, the occurrence of hyposmia may also predict a higher risk of PD. Investigations into hyposmia and its
Sheng Chen, Weidong Le
exaly +3 more sources
A Genome-Wide Screen for Hyposmia Susceptibility Loci [PDF]
Olfactory dysfunction is an important public health problem in the United States, with approximately 14 million elderly Americans having chronic olfactory impairment. We performed a genome-wide linkage scan for loci influencing susceptibility to hyposmia in the Hutterites, a founder population of European ancestry.
M Geoffrey Hayes +2 more
exaly +3 more sources
BackgroundOlfactory dysfunction is a common neurological symptom of Corona Virus Disease 2019(COVID-19). Little is known about hyposmia after COVID-19 infection with Omicron variant in Chinese population.ObjectiveTo investigate the incidence, clinical ...
Jun Shen +6 more
doaj +1 more source
Introduction The number of positive cases and deaths from the coronavirus disease 2019 (COVID-19) is still increasing. The early detection of the disease is very important.
Timotius Ivan Hariyanto +2 more
doaj +1 more source
Neurosensory dysfunction: A diagnostic marker of early COVID-19
Objective: To describe neurosensory dysfunctions, including hyposmia, hypogeusia, and tinnitus, in patients with COVID-19. Methods: Clinical characteristics and oropharyngeal swabs were obtained from 86 patients with COVID-19 hospitalized in Guangzhou ...
Yujie Liang +11 more
doaj +1 more source
Background: Non-motor symptoms in PD usually arise at very early stage and vary during the whole disease progression. Deep brain stimulation (DBS) is considered as a highly efficient treatment option for PD's motor function. However, the effect of DBS on
Chao Li +12 more
doaj +1 more source
Interleukin 6 in Hyposmia [PDF]
Olfaction is a complex sensory process that has not been fully studied. Elevated plasma levels of interleukin 6 (IL-6) have been found in patients with several acute and chronic diseases but have not been reported in patients with smell loss (hyposmia).To determine IL-6 levels in patients with hyposmia.Retrospective study.
Robert I, Henkin +2 more
openaire +2 more sources

